The epidemiology of diabetes mellitus, A.R.G. Humphrey et al; islet amyloid, islet amyloid polypeptide, islet function and glucose metabolism in diabetes, A. Clark et al; metabolic effects of insulin-like growth factor 1, W.P. Borg and R.S. Sherwin; the IRS-signalling system in insulin action, M.F. White; non-esterified fatty acids in non-insulin-dependent diabetes - a critical update, G. Periello et al; the role of fatty acid metabolism in the hypertriglyceridaemia and insulin resistance of type 2 (non-insulin dependent) diabetes, Y.T. Kruszynska; does pancreatic portal venous drainage matter?, J. Radziuk and P. Barron; protein metabolism in diabetes mellitus, K.S. Nair and W.F. Schwenk; the thiazolidinedione drug series, R.W. Stevenson et al; recent advances in insulin therapy, J.S. Skyler; aldose reductase and diabetes, D.R. Tomlinson; advanced glycation and diabetes complications - an update, H. Vlassura and R. Bucala; the basement membrane in diabetes, A.S. Reddi; role of nitric oxide in islet B-cell destruction associated with the development of autoimmune diabetes, J.A. Corbett et al; anti-hypertensive agents and incipient diabetic nephropathy, P. Ruggenenti and G. Remuzzi; alcohol and diabetes, V.A. Koivisto; diabetes care by the primary health care team - a review of the literature with some recommendations for the future, T. Lauritzen.
